<- Go Home
Synergy Innovation Co., Ltd.
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation – universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd. was founded in 1998 and is headquartered in Seongnam-Si, South Korea.
Market Cap
KRW 229.1B
Volume
1.3M
Cash and Equivalents
KRW 71.5B
EBITDA
KRW 20.3B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
KRW 37.9B
Profit Margin
41.79%
52 Week High
KRW 3.6K
52 Week Low
KRW 2.1K
Dividend
N/A
Price / Book Value
1.27
Price / Earnings
22.16
Price / Tangible Book Value
1.44
Enterprise Value
KRW 216.0B
Enterprise Value / EBITDA
7.22
Operating Income
KRW 16.1B
Return on Equity
7.93%
Return on Assets
3.36
Cash and Short Term Investments
KRW 106.5B
Debt
KRW 41.1B
Equity
KRW 235.1B
Revenue
KRW 90.6B
Unlevered FCF
KRW 12.6B
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium